- Home
- TRMK vs CLDX Comparison
TRMK vs CLDX Comparison
Compare TRMK & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRMK | CLDX |
|---|---|---|
| Founded | 1889 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TRMK | CLDX |
|---|---|---|
| Price | $42.59 | $31.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $43.50 | ★ $44.50 |
| AVG Volume (30 Days) | 364.6K | ★ 965.7K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 1.93 | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $9.49 | $111.39 |
| Revenue Next Year | $5.17 | $235.85 |
| P/E Ratio | $11.51 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $29.81 | $14.40 |
| 52 Week High | $45.43 | $34.52 |
Technical Indicators
Market Signals| Indicator | TRMK | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.85 | 56.01 |
| Support Level | $36.46 | $28.25 |
| Resistance Level | $43.29 | $34.52 |
| Average True Range (ATR) | 0.93 | 1.72 |
| MACD | 0.17 | -0.12 |
| Stochastic Oscillator | 86.87 | 47.58 |
Price Performance
Historical ComparisonAbout TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.